Almac’s Clinical Services business unit has introduced new containment equipment and processes at its EU and US headquarters to expand its service offering for dispensing and bottling solid dosage products.
According to the company, the facilities, having completed installation and validation, and are now operational.
Almac Clinical Services managing director Dr Robert Dunlop said the company has experienced an increase in demand for facilities equipped to handle compounds of a higher potency in recent years.
"This development at our European and North American Headquarters is the latest example of how Almac constantly strives to advance its service offering to reflect the needs of the drug development industry," Dunlop said.
Almac is now ready for packaging discussions with companies which have potent products in their pipeline.